C G Arcangeli

Learn More
OBJECTIVES Measurement of the percentage of free prostate-specific antigen (%FPSA) in serum can improve the specificity of prostate cancer screening. We evaluated the ability of %FPSA to predict pathologic features of screen-detected clinically localized prostate cancer. METHODS We evaluated the correlation between %FPSA in serum before cancer diagnosis(More)
Serum PSA-based early detection for prostate cancer has been studied fairly extensively for the past several years. It appears that we can state fairly categorically what the relative performances of total serum PSA, DRE, and TRUS are in detecting early-stage prostate cancer; that initial screening is effective in detecting histologically significant and(More)
PURPOSE Measurement of total serum prostate specific antigen (PSA) is widely used as an aid to early detection of prostate cancer. Measurement of the ratio of free-to-total PSA (percentage of free PSA) may help increase specificity of PSA testing. We prospectively studied the effects of varying the storage temperature and interval on total and free PSA(More)
Prostate cancer screening and early detection efforts have resulted in the identification of smaller volume carcinomas of the prostate. We evaluated the diagnostic features of minimal (< 1 mm) carcinoma in sextant needle biopsy specimens of the prostate and in follow-up analyzed the features of the corresponding carcinomas in the whole gland. We reviewed(More)
This article reviews the differential diagnoses for solid renal masses and staging for renal cell carcinoma, and also discusses several areas of controversy in regard to the management of solid renal masses, such as the role of nephron-sparing surgery, extended lymphadenectomy, and ipsilateral adrenalectomy. The management of renal cell carcinoma associated(More)
  • 1